Recent Press Releases

Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine

PRINCETON, N.J., Sept. 2, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious...

Surprising discovery: HIV hides in gut, evading eradication

(SACRAMENTO, Calif.) —Researchers at UC Davis have made some surprising discoveries about the body's initial responses to HIV infection. Studying simian immunodeficiency virus (SIV), the...

Mice study shows efficacy of new gene therapy approach for toxin exposures

NORTH GRAFTON, Mass. (August 29, 2014, 2 PM US Eastern Time)—The current method to treat acute toxin poisoning is to inject antibodies, commonly produced in animals, to neutralize the toxin....

Small molecule acts as on-off switch for nature's antibiotic factory

DURHAM, N.C. -- Scientists have identified the developmental on-off switch for Streptomyces, a group of soil microbes that produce more than two-thirds of the world's naturally derived antibiotic...

Study Identifies Protein that Helps Prevent Active Tuberculosis in Infected Patients

UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from...

Scientists grow an organ in an animal from cells created in lab

Laboratory-grown replacement organs have moved a step closer with the completion of a new study. Scientists have grown a fully functional organ from transplanted laboratory-created cells in a living...

Early bottlenecks in developing biopharmaceutical products delay commercialization

An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization. To open these roadblocks, the researchers suggest that...

Neurotrope's Approach to Treating Alzheimer's Disease Through Its Product Bryostatin-1, an Activator of Protein Kinase C Epsilon (PKCe), Supported by Blanchette Rockefeller Neurosciences Institute (BRNI) Publication, Identifying PKCe as a Biomarker of Alz

PLANTATION, Fla., Aug. 18, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) today announced that results from a new study, entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin...

Novartis provides drug candidate compounds to TB Alliance

Basel, August 20, 2014 - Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tuberculosis (TB) that...

Single enzyme necessary for development of diabetes

WASHINGTON, DC – August 14, 2014 – An enzyme called 12-LO promotes the obesity-induced oxidative stress in the pancreatic cells that leads to pre-diabetes, and diabetes. 12-LO's...

Injected Bacteria Shrink Tumors in Rats, Dogs and Humans

A modified version of the Clostridium novyi (C. novyi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns...

RTI International develops novel lung-on-a-chip

RESEARCH TRIANGLE PARK, N.C. — Researchers at RTI International, in collaboration with the University of North Carolina at Chapel Hill, have developed a new lung-on-chip microdevice for...

Ebola Protein Blocks Early Step in Body's Counterattack on Virus

One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses. Over time, many...

HIGHLY DRUG RESISTANT, VIRULENT STRAIN OF PSEUDOMONAS AERUGINOSA ARISES IN OHIO

WASHINGTON, DC – August 11, 2014 – A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples...

Bioengineers Make Functional 3D Brain-Like Tissue Model

MEDFORD/SOMERVILLE, Mass. (August 11, 2014) --The human brain remains one of the least understood organs in the human body, because of its complexity and the difficulty of studying its physiology in...

In search for Alzheimer's drug, a major STEP forward

Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer's disease in an animal model. Their findings are published in the Aug. 5...

TSRI Laboratories Perform Crucial Research in Development of Promising Ebola Virus Treatment

TSRI Laboratories Perform Crucial Research in Development of Promising Ebola Virus Treatment LA JOLLA, CA – August 5, 2014 - Laboratories at The Scripps Research Institute (TSRI) are...

A Vaccine Alternative Protects Mice Against Malaria

A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a...

Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax

PRINCETON, N.J., Aug. 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious...

Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy

SOUTH PLAINFIELD, N.J., Aug. 7, 2014 /PRNewswire/ -- Today the journal Science published results of a preclinical study demonstrating that treatment with orally available RNA splicing modifiers of...